Jon Berridge

Title: Innovations by Jon Berridge in Tumor Treatment Technologies

Introduction

Jon Berridge, located in Oakland, CA, is a notable inventor in the field of medical technologies, with a remarkable portfolio featuring 10 patents. His innovative work primarily focuses on methods and devices that utilize nanosecond pulsed electric fields (nsPEF) to stimulate immune responses, offering promising solutions against various types of tumors.

Latest Patents

One of Jon Berridge’s latest patents details methods and devices for stimulating an immune response using nanosecond pulsed electric fields. This technique involves adjusting nsPEF treatments according to the size and type of tumors present, effectively stimulating an immune response both against the identified tumor and any additional tumors in the subject. The treatment’s efficacy is confirmed through the detection of calreticulin expression on tumor cells, allowing for further treatments if necessary. Notably, the method can be utilized to address cancers that have metastasized by directly targeting the most accessible tumors. Furthermore, the treatments can be enhanced through a combination with CD47-blocking antibodies, doxorubicin, CTLA-4-blocking antibodies, and PD-1-blocking antibodies. The electrical characteristics of nsPEF treatments are meticulously tailored based on tumor characteristics.

Career Highlights

Over the course of his career, Jon has made significant contributions to the field through his work with respected companies such as Pulse Biosciences, Inc. and Nanoblate Corporation. His innovative efforts have positioned him as a key player in the development of advanced cancer treatment technologies, showcasing a deep understanding of both the biological and electrical aspects of tumor treatment.

Collaborations

Jon Berridge has collaborated with esteemed colleagues, including Richard Lee Nuccitelli and Pamela S Nuccitelli, to advance the research and applications of his groundbreaking technologies. Through these partnerships, he has enhanced the effectiveness of treatment methodologies and expanded the potential for future innovations in cancer therapies.

Conclusion

Jon Berridge's dedication to advancing treatment options for cancer through cutting-edge technology marks him as an influential inventor in the medical field. His patents reflect a commitment to addressing complex medical challenges and improving patient outcomes in tumor treatments. With a strong foundation in innovation and collaboration, Jon continues to make strides in the fight against cancer.